SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-009002
Filing Date
2020-05-15
Accepted
2020-05-15 13:23:08
Documents
52
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 558545
2 ex31-1.htm EX-31.1 13654
3 ex31-2.htm EX-31.2 13716
4 ex32-1.htm EX-32.1 13023
  Complete submission text file 0001493152-20-009002.txt   2286118

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pcsa-20200331.xml EX-101.INS 211869
6 XBRL SCHEMA FILE pcsa-20200331.xsd EX-101.SCH 45253
7 XBRL CALCULATION FILE pcsa-20200331_cal.xml EX-101.CAL 43898
8 XBRL DEFINITION FILE pcsa-20200331_def.xml EX-101.DEF 82529
9 XBRL LABEL FILE pcsa-20200331_lab.xml EX-101.LAB 236965
10 XBRL PRESENTATION FILE pcsa-20200331_pre.xml EX-101.PRE 156162
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-184948 | Film No.: 20883280
SIC: 2834 Pharmaceutical Preparations